The purpose of this study is to compare the efficacy of CPAP application by a helmet and O2 administration by a Venturi mask in terms of achievement of criteria for endotracheal intubation during severe acute respiratory failure caused by pneumonia
Pneumonia is one of the commonest causes of hospitalised acute respiratory failure with a mortality rate up to 30%. Continuous Positive Airway Pressure (CPAP) has ben recently proved to be effective. To date, however, no prospective randomised study has been published on the comparison between CPAP and O2 administration by Venturi mask for the treatment of severe acute respiratory failure in patients with pneumonia. .
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
81
patient in group oxygen therapy by Venturi Mask will be treated with oxygen until reaching clinical stability, or criteria of endotracheal intubation
patient in group CPAP will be treated with CPAP until reaching clinical stability, or criteria of endotracheal intubation
Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico
Milan, Milan, Italy
to Evaluate the Efficacy of CPAP (Group A) in Comparison With Oxygen Therapy With Venturi Mask (Group B, Standard Therapy) in Terms of Achievement of Criteria for Endotracheal Intubation.
Endotracheale intubation criteria:≥1 among the major criteria or ≥2 among the minor criteria MAJOR CRITERIA:Respiratory arrest;Respiratory pauses with unconsciousness;Severe hemodynamic instability; Need of sedation MINOR CRITERIA:Reduction ≥ 30% of basal PaO2/FiO2; Increasing of 20% PaCO2 if basal PaCO2 is≥40mmHg; Worsening of alertness;Distress;SpO2\<90%;Exhaustion. The reaching of these criteria does not automatically imply the actual intubation of the patient, since this decision will depend on the treating physician.
Time frame: the reaching of the following endotracheal intubation criteria maintained for at least one hour:
to Compare the Efficacy of the Two Treatments in Terms of In-hospital Mortality
The secondary endpoint of this study will be evaluated, if appropriate, on 3 subpopulations composed of: 1. CPAP: patients randomised to CPAP treatment who have changed treatment only after the reaching of the primary endpoint 2. Control: patients randomised to Venturi mask treatment 3. Mixed: patients who, after the treatment with Venturi mask, have needed to be treated with non-invasive CPAP
Time frame: participants will be followed for the duration of hospital stay, an expected average of 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.